prof. Nico Callewaert (PhD)
Group leader, Medical Biotechnology Unit, VIB-UGent
Department director, Center for Medical Biotechnology, VIB-UGent
Member of the management committee, VIB
Full professor in biochemistry and biotechnology (Faculty of Sciences, UGent)
At the Medical Biotechnology lab we are developing glycomics and glycoproteomics-based biomarker assays for use in the diagnosis and targeting of cancer. Our most advanced marker is GlycoCirrhoTest, which is a blood serum marker that allows to diagnose the premalign proliferative activity of hepatocytes in cirrhosis as soon as it occurs. This is the most important risk factor for hepatocellular carcinoma and identifies those patients that should be closely monitored for this highly prevalent cancer, which is expected to lead to earlier detection and more chance on curative treatment.
More recent project are targeted at innovations in early detection of cancer-associated alterations in circulating free tumor DNA and in immunotherapy.
We also bring deep expertise in the protein biopharmaceutical area to CRIG.